Cognitive Slowing May Be a Hallmark of Long COVID
Pronounced cognitive slowing distinguished people with long COVID from others, a cross-sectional study showed. On a 30-second task measuring simple reaction time, moderate-to-severe cognitive slowing was evident among long COVID patients compared with age-matched healthy individuals who had previous symptomatic SARS-CoV-2 infection and recovered, reported Sijia Zhao, PhD, at the University of Oxford in England, […]
Finerenone OK’d for Slowing Kidney Disease in T2D
The FDA approved the anti-mineralocorticoid agent finerenone (Kerendia) for slowing the progression of chronic kidney disease in type 2 diabetes patients, the agency announced on Friday. The first non-steroidal, selective mineralocorticoid receptor antagonist was approved to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, […]